Evidence map›Paper›PMID 25045259›Full record

ArticleInternational journal of nanomedicine2014

Dose intensity and autologous stem cell transplantation as salvage therapy for pediatric primary CNS malignancies.

Seiji Kojima, Andrei Cucuianu, Yoshiyuki Takahashi, Ioana Berindan-Neagoe, Ioan-Stefan Florian, Delia Dima, Ciprian Tomuleasa

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Seiji KojimaDepartment of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Andrei CucuianuDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania ; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Yoshiyuki TakahashiDepartment of Paediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ioana Berindan-NeagoeDepartment of Functional Genomics and Experimental Pathology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania ; Department of Immunology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania ; Research Center for Functional Genomics, Biomedicine and Translational Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Ioan-Stefan FlorianDepartment of Neurosurgery, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
Delia DimaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.
Ciprian TomuleasaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania ; Department of Functional Genomics and Experimental Pathology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBlood-Brain BarrierCentral Nervous System AgentsHumansMolecular Targeted TherapyNanocapsulesCentral Nervous System AgentsNanocapsules

Identifiers

PMID25045259
PMCPMC4094582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.